Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04510636
Status:
RECRUITING
Last Update Posted:
2024-03-22
First Post:
2020-08-09
Brief Title:
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Classical Hodgkin Lymphoma |
| Relapsed Cancer |
| Refractory Cancer |
Keywords: